nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—multiple sclerosis	0.445	1	CbGaD
Epinephrine—SLC22A2—Cladribine—multiple sclerosis	0.0962	0.336	CbGbCtD
Epinephrine—SLC22A1—Cladribine—multiple sclerosis	0.0835	0.292	CbGbCtD
Epinephrine—CYP3A4—Fingolimod—multiple sclerosis	0.0238	0.0831	CbGbCtD
Epinephrine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0153	0.0535	CbGbCtD
Epinephrine—CYP3A4—Triamcinolone—multiple sclerosis	0.0116	0.0406	CbGbCtD
Epinephrine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0112	0.039	CbGbCtD
Epinephrine—CYP2C9—Dexamethasone—multiple sclerosis	0.00997	0.0348	CbGbCtD
Epinephrine—CYP3A4—Betamethasone—multiple sclerosis	0.00997	0.0348	CbGbCtD
Epinephrine—CYP3A4—Prednisolone—multiple sclerosis	0.00984	0.0343	CbGbCtD
Epinephrine—CYP3A4—Prednisone—multiple sclerosis	0.00929	0.0324	CbGbCtD
Epinephrine—CYP3A4—Dexamethasone—multiple sclerosis	0.0058	0.0202	CbGbCtD
Epinephrine—ADRBK1—peripheral nervous system—multiple sclerosis	0.00467	0.2	CbGeAlD
Epinephrine—Cerebral haemorrhage—Fingolimod—multiple sclerosis	0.00388	0.0386	CcSEcCtD
Epinephrine—Rales—Cladribine—multiple sclerosis	0.00297	0.0295	CcSEcCtD
Epinephrine—Ischaemia—Mitoxantrone—multiple sclerosis	0.00219	0.0218	CcSEcCtD
Epinephrine—Cerebrovascular accident—Fingolimod—multiple sclerosis	0.00159	0.0158	CcSEcCtD
Epinephrine—Isoprenaline—MAPK1—multiple sclerosis	0.00154	0.389	CrCbGaD
Epinephrine—Myocardial ischaemia—Cladribine—multiple sclerosis	0.00151	0.0151	CcSEcCtD
Epinephrine—Local reaction—Mitoxantrone—multiple sclerosis	0.00144	0.0144	CcSEcCtD
Epinephrine—Extravasation—Cladribine—multiple sclerosis	0.00139	0.0139	CcSEcCtD
Epinephrine—Contusion—Cladribine—multiple sclerosis	0.00139	0.0139	CcSEcCtD
Epinephrine—Dipivefrin—BCHE—multiple sclerosis	0.0013	0.327	CrCbGaD
Epinephrine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00118	0.0503	CbGeAlD
Epinephrine—Skin necrosis—Methotrexate—multiple sclerosis	0.00114	0.0113	CcSEcCtD
Epinephrine—Terbutaline—BCHE—multiple sclerosis	0.00112	0.284	CrCbGaD
Epinephrine—PAH—nervous system—multiple sclerosis	0.00107	0.046	CbGeAlD
Epinephrine—PAH—central nervous system—multiple sclerosis	0.00103	0.0442	CbGeAlD
Epinephrine—Necrosis—Mitoxantrone—multiple sclerosis	0.00102	0.0101	CcSEcCtD
Epinephrine—Myocardial ischaemia—Mitoxantrone—multiple sclerosis	0.000995	0.0099	CcSEcCtD
Epinephrine—Disorientation—Cladribine—multiple sclerosis	0.000988	0.00982	CcSEcCtD
Epinephrine—Rales—Methotrexate—multiple sclerosis	0.000971	0.00966	CcSEcCtD
Epinephrine—Mental disorder—Fingolimod—multiple sclerosis	0.000945	0.00939	CcSEcCtD
Epinephrine—Renal impairment—Cladribine—multiple sclerosis	0.000928	0.00923	CcSEcCtD
Epinephrine—Extravasation—Mitoxantrone—multiple sclerosis	0.000917	0.00912	CcSEcCtD
Epinephrine—Contusion—Mitoxantrone—multiple sclerosis	0.000917	0.00912	CcSEcCtD
Epinephrine—Cerebrovascular accident—Cladribine—multiple sclerosis	0.000902	0.00896	CcSEcCtD
Epinephrine—Nephropathy—Methotrexate—multiple sclerosis	0.000837	0.00832	CcSEcCtD
Epinephrine—Palpitations—Fingolimod—multiple sclerosis	0.000829	0.00825	CcSEcCtD
Epinephrine—Mydriasis—Prednisolone—multiple sclerosis	0.000823	0.00818	CcSEcCtD
Epinephrine—PAH—brain—multiple sclerosis	0.00082	0.0351	CbGeAlD
Epinephrine—ADRBK1—nervous system—multiple sclerosis	0.000819	0.0351	CbGeAlD
Epinephrine—Hypertension—Fingolimod—multiple sclerosis	0.00081	0.00806	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.000794	0.00789	CcSEcCtD
Epinephrine—ADRBK1—central nervous system—multiple sclerosis	0.000789	0.0338	CbGeAlD
Epinephrine—ADRBK1—cerebellum—multiple sclerosis	0.000771	0.033	CbGeAlD
Epinephrine—Necrosis—Methylprednisolone—multiple sclerosis	0.000767	0.00763	CcSEcCtD
Epinephrine—Nervous system disorder—Fingolimod—multiple sclerosis	0.000751	0.00747	CcSEcCtD
Epinephrine—Tingling sensation—Methylprednisolone—multiple sclerosis	0.000749	0.00745	CcSEcCtD
Epinephrine—Skin disorder—Fingolimod—multiple sclerosis	0.000744	0.0074	CcSEcCtD
Epinephrine—Sweating increased—Cladribine—multiple sclerosis	0.000744	0.0074	CcSEcCtD
Epinephrine—Necrosis—Betamethasone—multiple sclerosis	0.000698	0.00694	CcSEcCtD
Epinephrine—Necrosis—Dexamethasone—multiple sclerosis	0.000698	0.00694	CcSEcCtD
Epinephrine—Paraesthesia—Fingolimod—multiple sclerosis	0.000688	0.00684	CcSEcCtD
Epinephrine—Tingling sensation—Dexamethasone—multiple sclerosis	0.000681	0.00677	CcSEcCtD
Epinephrine—Tingling sensation—Betamethasone—multiple sclerosis	0.000681	0.00677	CcSEcCtD
Epinephrine—Renal failure—Cladribine—multiple sclerosis	0.000669	0.00665	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000661	0.00658	CcSEcCtD
Epinephrine—Contusion—Dexamethasone—multiple sclerosis	0.000628	0.00624	CcSEcCtD
Epinephrine—Extravasation—Dexamethasone—multiple sclerosis	0.000628	0.00624	CcSEcCtD
Epinephrine—Extravasation—Betamethasone—multiple sclerosis	0.000628	0.00624	CcSEcCtD
Epinephrine—Contusion—Betamethasone—multiple sclerosis	0.000628	0.00624	CcSEcCtD
Epinephrine—ADRBK1—brain—multiple sclerosis	0.000626	0.0268	CbGeAlD
Epinephrine—Haemoglobin—Cladribine—multiple sclerosis	0.000614	0.00611	CcSEcCtD
Epinephrine—Haemorrhage—Cladribine—multiple sclerosis	0.000611	0.00608	CcSEcCtD
Epinephrine—Necrosis—Prednisone—multiple sclerosis	0.000608	0.00604	CcSEcCtD
Epinephrine—Memory impairment—Prednisone—multiple sclerosis	0.000608	0.00604	CcSEcCtD
Epinephrine—Pulmonary oedema—Prednisolone—multiple sclerosis	0.000584	0.00581	CcSEcCtD
Epinephrine—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000576	0.00573	CcSEcCtD
Epinephrine—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000575	0.00572	CcSEcCtD
Epinephrine—Contusion—Prednisone—multiple sclerosis	0.000547	0.00544	CcSEcCtD
Epinephrine—Arrhythmia—Cladribine—multiple sclerosis	0.000546	0.00543	CcSEcCtD
Epinephrine—Pulmonary oedema—Triamcinolone—multiple sclerosis	0.000537	0.00534	CcSEcCtD
Epinephrine—Pulmonary oedema—Methylprednisolone—multiple sclerosis	0.000536	0.00533	CcSEcCtD
Epinephrine—Mental disorder—Cladribine—multiple sclerosis	0.000535	0.00532	CcSEcCtD
Epinephrine—Erythema—Cladribine—multiple sclerosis	0.000532	0.00529	CcSEcCtD
Epinephrine—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.000528	0.00525	CcSEcCtD
Epinephrine—Skin exfoliation—Betamethasone—multiple sclerosis	0.000523	0.0052	CcSEcCtD
Epinephrine—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000523	0.0052	CcSEcCtD
Epinephrine—ADRA1A—brainstem—multiple sclerosis	0.000517	0.0222	CbGeAlD
Epinephrine—Necrosis—Methotrexate—multiple sclerosis	0.000508	0.00505	CcSEcCtD
Epinephrine—Dizziness—Fingolimod—multiple sclerosis	0.000507	0.00504	CcSEcCtD
Epinephrine—Haemoglobin—Azathioprine—multiple sclerosis	0.000499	0.00497	CcSEcCtD
Epinephrine—Haemorrhage—Azathioprine—multiple sclerosis	0.000497	0.00494	CcSEcCtD
Epinephrine—Sweating increased—Mitoxantrone—multiple sclerosis	0.000489	0.00486	CcSEcCtD
Epinephrine—Pulmonary oedema—Betamethasone—multiple sclerosis	0.000487	0.00485	CcSEcCtD
Epinephrine—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.000487	0.00485	CcSEcCtD
Epinephrine—ADRA1B—nervous system—multiple sclerosis	0.000482	0.0207	CbGeAlD
Epinephrine—ADRA1D—nervous system—multiple sclerosis	0.000472	0.0202	CbGeAlD
Epinephrine—ADRA1B—central nervous system—multiple sclerosis	0.000464	0.0199	CbGeAlD
Epinephrine—Extravasation—Methotrexate—multiple sclerosis	0.000457	0.00454	CcSEcCtD
Epinephrine—SLC22A5—retina—multiple sclerosis	0.000455	0.0195	CbGeAlD
Epinephrine—Skin exfoliation—Prednisone—multiple sclerosis	0.000455	0.00453	CcSEcCtD
Epinephrine—ADRA1D—central nervous system—multiple sclerosis	0.000454	0.0195	CbGeAlD
Epinephrine—Chest pain—Cladribine—multiple sclerosis	0.000453	0.0045	CcSEcCtD
Epinephrine—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000453	0.0045	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00045	0.00447	CcSEcCtD
Epinephrine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000447	0.00445	CcSEcCtD
Epinephrine—Arrhythmia—Azathioprine—multiple sclerosis	0.000444	0.00441	CcSEcCtD
Epinephrine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000441	0.00439	CcSEcCtD
Epinephrine—Renal failure—Mitoxantrone—multiple sclerosis	0.00044	0.00437	CcSEcCtD
Epinephrine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000439	0.00436	CcSEcCtD
Epinephrine—Sweating—Mitoxantrone—multiple sclerosis	0.000429	0.00427	CcSEcCtD
Epinephrine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000427	0.00425	CcSEcCtD
Epinephrine—Nervous system disorder—Cladribine—multiple sclerosis	0.000426	0.00423	CcSEcCtD
Epinephrine—Pulmonary oedema—Prednisone—multiple sclerosis	0.000424	0.00422	CcSEcCtD
Epinephrine—Tachycardia—Cladribine—multiple sclerosis	0.000424	0.00421	CcSEcCtD
Epinephrine—Skin disorder—Cladribine—multiple sclerosis	0.000422	0.00419	CcSEcCtD
Epinephrine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00042	0.00417	CcSEcCtD
Epinephrine—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000404	0.00401	CcSEcCtD
Epinephrine—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000402	0.00399	CcSEcCtD
Epinephrine—Sweating increased—Prednisolone—multiple sclerosis	0.000401	0.00399	CcSEcCtD
Epinephrine—Insomnia—Cladribine—multiple sclerosis	0.000393	0.0039	CcSEcCtD
Epinephrine—Paraesthesia—Cladribine—multiple sclerosis	0.00039	0.00388	CcSEcCtD
Epinephrine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000388	0.00386	CcSEcCtD
Epinephrine—Psychotic disorder—Betamethasone—multiple sclerosis	0.000388	0.00386	CcSEcCtD
Epinephrine—Somnolence—Cladribine—multiple sclerosis	0.000386	0.00384	CcSEcCtD
Epinephrine—Skin exfoliation—Methotrexate—multiple sclerosis	0.000381	0.00378	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000375	0.00373	CcSEcCtD
Epinephrine—Sweating increased—Triamcinolone—multiple sclerosis	0.000369	0.00367	CcSEcCtD
Epinephrine—ADRA1B—brain—multiple sclerosis	0.000369	0.0158	CbGeAlD
Epinephrine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000368	0.00366	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000366	0.00364	CcSEcCtD
Epinephrine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000362	0.0036	CcSEcCtD
Epinephrine—Hypokalaemia—Betamethasone—multiple sclerosis	0.000362	0.0036	CcSEcCtD
Epinephrine—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000362	0.0036	CcSEcCtD
Epinephrine—ADRA1D—brain—multiple sclerosis	0.000361	0.0154	CbGeAlD
Epinephrine—Myocardial infarction—Prednisolone—multiple sclerosis	0.00036	0.00358	CcSEcCtD
Epinephrine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000359	0.00357	CcSEcCtD
Epinephrine—SLC22A1—nervous system—multiple sclerosis	0.000356	0.0152	CbGeAlD
Epinephrine—Pulmonary oedema—Methotrexate—multiple sclerosis	0.000355	0.00353	CcSEcCtD
Epinephrine—Erythema—Mitoxantrone—multiple sclerosis	0.00035	0.00348	CcSEcCtD
Epinephrine—ADRA2C—medulla oblongata—multiple sclerosis	0.000344	0.0147	CbGeAlD
Epinephrine—Skin disorder—Azathioprine—multiple sclerosis	0.000343	0.00341	CcSEcCtD
Epinephrine—ADRB1—nervous system—multiple sclerosis	0.000343	0.0147	CbGeAlD
Epinephrine—SLC22A1—central nervous system—multiple sclerosis	0.000343	0.0147	CbGeAlD
Epinephrine—Psychotic disorder—Prednisone—multiple sclerosis	0.000338	0.00336	CcSEcCtD
Epinephrine—Sweating increased—Betamethasone—multiple sclerosis	0.000335	0.00333	CcSEcCtD
Epinephrine—Sweating increased—Dexamethasone—multiple sclerosis	0.000335	0.00333	CcSEcCtD
Epinephrine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000333	0.00331	CcSEcCtD
Epinephrine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000332	0.0033	CcSEcCtD
Epinephrine—Haemoglobin—Prednisolone—multiple sclerosis	0.000331	0.00329	CcSEcCtD
Epinephrine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000331	0.00329	CcSEcCtD
Epinephrine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00033	0.00328	CcSEcCtD
Epinephrine—ADRB1—central nervous system—multiple sclerosis	0.00033	0.0141	CbGeAlD
Epinephrine—Haemorrhage—Prednisolone—multiple sclerosis	0.00033	0.00328	CcSEcCtD
Epinephrine—SLC22A5—medulla oblongata—multiple sclerosis	0.000329	0.0141	CbGeAlD
Epinephrine—Sweating—Methylprednisolone—multiple sclerosis	0.000323	0.00321	CcSEcCtD
Epinephrine—Hypokalaemia—Prednisone—multiple sclerosis	0.000315	0.00313	CcSEcCtD
Epinephrine—ADRA2C—midbrain—multiple sclerosis	0.000314	0.0135	CbGeAlD
Epinephrine—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00031	0.00308	CcSEcCtD
Epinephrine—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00031	0.00308	CcSEcCtD
Epinephrine—ADRA2C—spinal cord—multiple sclerosis	0.000306	0.0131	CbGeAlD
Epinephrine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000305	0.00303	CcSEcCtD
Epinephrine—Haemoglobin—Triamcinolone—multiple sclerosis	0.000305	0.00303	CcSEcCtD
Epinephrine—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000304	0.00302	CcSEcCtD
Epinephrine—Haemorrhage—Triamcinolone—multiple sclerosis	0.000303	0.00301	CcSEcCtD
Epinephrine—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000302	0.00301	CcSEcCtD
Epinephrine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000302	0.003	CcSEcCtD
Epinephrine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000302	0.003	CcSEcCtD
Epinephrine—Hypertension—Mitoxantrone—multiple sclerosis	0.000302	0.003	CcSEcCtD
Epinephrine—Hallucination—Methylprednisolone—multiple sclerosis	0.000301	0.00299	CcSEcCtD
Epinephrine—SLC22A5—midbrain—multiple sclerosis	0.000301	0.0129	CbGeAlD
Epinephrine—Myocardial infarction—Betamethasone—multiple sclerosis	0.0003	0.00299	CcSEcCtD
Epinephrine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.0003	0.00299	CcSEcCtD
Epinephrine—Chest pain—Mitoxantrone—multiple sclerosis	0.000298	0.00296	CcSEcCtD
Epinephrine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000295	0.00294	CcSEcCtD
Epinephrine—Arrhythmia—Prednisolone—multiple sclerosis	0.000294	0.00293	CcSEcCtD
Epinephrine—SLC22A5—spinal cord—multiple sclerosis	0.000294	0.0126	CbGeAlD
Epinephrine—Sweating increased—Prednisone—multiple sclerosis	0.000291	0.0029	CcSEcCtD
Epinephrine—Dizziness—Cladribine—multiple sclerosis	0.000287	0.00286	CcSEcCtD
Epinephrine—Erythema—Prednisolone—multiple sclerosis	0.000287	0.00285	CcSEcCtD
Epinephrine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000279	0.00277	CcSEcCtD
Epinephrine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000277	0.00276	CcSEcCtD
Epinephrine—Haemoglobin—Dexamethasone—multiple sclerosis	0.000276	0.00275	CcSEcCtD
Epinephrine—Haemoglobin—Betamethasone—multiple sclerosis	0.000276	0.00275	CcSEcCtD
Epinephrine—Vomiting—Cladribine—multiple sclerosis	0.000276	0.00275	CcSEcCtD
Epinephrine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000276	0.00274	CcSEcCtD
Epinephrine—Haemorrhage—Dexamethasone—multiple sclerosis	0.000275	0.00273	CcSEcCtD
Epinephrine—Haemorrhage—Betamethasone—multiple sclerosis	0.000275	0.00273	CcSEcCtD
Epinephrine—ADRA2A—medulla oblongata—multiple sclerosis	0.000274	0.0117	CbGeAlD
Epinephrine—Hallucination—Betamethasone—multiple sclerosis	0.000274	0.00272	CcSEcCtD
Epinephrine—Hallucination—Dexamethasone—multiple sclerosis	0.000274	0.00272	CcSEcCtD
Epinephrine—SLC22A1—brain—multiple sclerosis	0.000272	0.0117	CbGeAlD
Epinephrine—ADRA1A—nervous system—multiple sclerosis	0.000271	0.0116	CbGeAlD
Epinephrine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000271	0.00269	CcSEcCtD
Epinephrine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00027	0.00269	CcSEcCtD
Epinephrine—Hyperglycaemia—Prednisone—multiple sclerosis	0.00027	0.00268	CcSEcCtD
Epinephrine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000265	0.00263	CcSEcCtD
Epinephrine—Erythema—Triamcinolone—multiple sclerosis	0.000264	0.00262	CcSEcCtD
Epinephrine—Erythema—Methylprednisolone—multiple sclerosis	0.000263	0.00262	CcSEcCtD
Epinephrine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000263	0.00262	CcSEcCtD
Epinephrine—ADRB1—brain—multiple sclerosis	0.000262	0.0112	CbGeAlD
Epinephrine—Myocardial infarction—Prednisone—multiple sclerosis	0.000262	0.0026	CcSEcCtD
Epinephrine—ADRA1A—central nervous system—multiple sclerosis	0.000261	0.0112	CbGeAlD
Epinephrine—ADRA2C—nervous system—multiple sclerosis	0.000258	0.0111	CbGeAlD
Epinephrine—Nausea—Cladribine—multiple sclerosis	0.000258	0.00256	CcSEcCtD
Epinephrine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000256	0.00255	CcSEcCtD
Epinephrine—ADRA1A—cerebellum—multiple sclerosis	0.000255	0.0109	CbGeAlD
Epinephrine—Somnolence—Mitoxantrone—multiple sclerosis	0.000254	0.00252	CcSEcCtD
Epinephrine—ADRA2A—midbrain—multiple sclerosis	0.000251	0.0107	CbGeAlD
Epinephrine—ADRA2C—central nervous system—multiple sclerosis	0.000249	0.0106	CbGeAlD
Epinephrine—Hypertension—Prednisolone—multiple sclerosis	0.000248	0.00246	CcSEcCtD
Epinephrine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000246	0.00244	CcSEcCtD
Epinephrine—Arrhythmia—Betamethasone—multiple sclerosis	0.000246	0.00244	CcSEcCtD
Epinephrine—ADRA2A—spinal cord—multiple sclerosis	0.000245	0.0105	CbGeAlD
Epinephrine—ADRA2C—cerebellum—multiple sclerosis	0.000243	0.0104	CbGeAlD
Epinephrine—Haemoglobin—Prednisone—multiple sclerosis	0.000241	0.00239	CcSEcCtD
Epinephrine—Haemorrhage—Prednisone—multiple sclerosis	0.000239	0.00238	CcSEcCtD
Epinephrine—Erythema—Dexamethasone—multiple sclerosis	0.000239	0.00238	CcSEcCtD
Epinephrine—Erythema—Betamethasone—multiple sclerosis	0.000239	0.00238	CcSEcCtD
Epinephrine—Hallucination—Prednisone—multiple sclerosis	0.000238	0.00237	CcSEcCtD
Epinephrine—Dizziness—Azathioprine—multiple sclerosis	0.000233	0.00232	CcSEcCtD
Epinephrine—SLC22A5—cerebellum—multiple sclerosis	0.000233	0.00997	CbGeAlD
Epinephrine—Tachycardia—Prednisolone—multiple sclerosis	0.000229	0.00227	CcSEcCtD
Epinephrine—Hypertension—Triamcinolone—multiple sclerosis	0.000228	0.00226	CcSEcCtD
Epinephrine—Hypertension—Methylprednisolone—multiple sclerosis	0.000227	0.00226	CcSEcCtD
Epinephrine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000226	0.00225	CcSEcCtD
Epinephrine—Vomiting—Azathioprine—multiple sclerosis	0.000224	0.00223	CcSEcCtD
Epinephrine—Drowsiness—Methotrexate—multiple sclerosis	0.000223	0.00222	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000223	0.00221	CcSEcCtD
Epinephrine—Flushing—Prednisone—multiple sclerosis	0.000222	0.00221	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—multiple sclerosis	0.000219	0.00218	CcSEcCtD
Epinephrine—Arrhythmia—Prednisone—multiple sclerosis	0.000214	0.00213	CcSEcCtD
Epinephrine—Sweating—Methotrexate—multiple sclerosis	0.000214	0.00213	CcSEcCtD
Epinephrine—Insomnia—Prednisolone—multiple sclerosis	0.000212	0.00211	CcSEcCtD
Epinephrine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000211	0.0021	CcSEcCtD
Epinephrine—Paraesthesia—Prednisolone—multiple sclerosis	0.00021	0.00209	CcSEcCtD
Epinephrine—Tachycardia—Triamcinolone—multiple sclerosis	0.00021	0.00209	CcSEcCtD
Epinephrine—Mental disorder—Prednisone—multiple sclerosis	0.00021	0.00209	CcSEcCtD
Epinephrine—Nausea—Azathioprine—multiple sclerosis	0.00021	0.00209	CcSEcCtD
Epinephrine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00021	0.00208	CcSEcCtD
Epinephrine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000209	0.00208	CcSEcCtD
Epinephrine—Erythema—Prednisone—multiple sclerosis	0.000208	0.00207	CcSEcCtD
Epinephrine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000208	0.00207	CcSEcCtD
Epinephrine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000208	0.00207	CcSEcCtD
Epinephrine—ADRA1A—brain—multiple sclerosis	0.000207	0.00887	CbGeAlD
Epinephrine—Hypertension—Dexamethasone—multiple sclerosis	0.000207	0.00206	CcSEcCtD
Epinephrine—Hypertension—Betamethasone—multiple sclerosis	0.000207	0.00206	CcSEcCtD
Epinephrine—ADRA2A—nervous system—multiple sclerosis	0.000206	0.00882	CbGeAlD
Epinephrine—Haemoglobin—Methotrexate—multiple sclerosis	0.000201	0.002	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—multiple sclerosis	0.0002	0.00199	CcSEcCtD
Epinephrine—ADRA2A—central nervous system—multiple sclerosis	0.000198	0.0085	CbGeAlD
Epinephrine—ADRA2C—brain—multiple sclerosis	0.000197	0.00845	CbGeAlD
Epinephrine—Insomnia—Triamcinolone—multiple sclerosis	0.000195	0.00194	CcSEcCtD
Epinephrine—Insomnia—Methylprednisolone—multiple sclerosis	0.000194	0.00193	CcSEcCtD
Epinephrine—ADRA2A—cerebellum—multiple sclerosis	0.000194	0.0083	CbGeAlD
Epinephrine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000193	0.00192	CcSEcCtD
Epinephrine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000193	0.00192	CcSEcCtD
Epinephrine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000192	0.00191	CcSEcCtD
Epinephrine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000192	0.00191	CcSEcCtD
Epinephrine—Agitation—Prednisone—multiple sclerosis	0.000192	0.00191	CcSEcCtD
Epinephrine—Tachycardia—Dexamethasone—multiple sclerosis	0.000191	0.0019	CcSEcCtD
Epinephrine—Tachycardia—Betamethasone—multiple sclerosis	0.000191	0.0019	CcSEcCtD
Epinephrine—SLC22A5—brain—multiple sclerosis	0.000189	0.0081	CbGeAlD
Epinephrine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000189	0.00188	CcSEcCtD
Epinephrine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000189	0.00188	CcSEcCtD
Epinephrine—Vomiting—Mitoxantrone—multiple sclerosis	0.000181	0.0018	CcSEcCtD
Epinephrine—Hypertension—Prednisone—multiple sclerosis	0.00018	0.00179	CcSEcCtD
Epinephrine—Insomnia—Dexamethasone—multiple sclerosis	0.000177	0.00176	CcSEcCtD
Epinephrine—Insomnia—Betamethasone—multiple sclerosis	0.000177	0.00176	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000176	0.00175	CcSEcCtD
Epinephrine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000175	0.00174	CcSEcCtD
Epinephrine—Paraesthesia—Betamethasone—multiple sclerosis	0.000175	0.00174	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—multiple sclerosis	0.000175	0.00174	CcSEcCtD
Epinephrine—Erythema—Methotrexate—multiple sclerosis	0.000174	0.00173	CcSEcCtD
Epinephrine—Nausea—Mitoxantrone—multiple sclerosis	0.00017	0.00169	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000169	0.00168	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000169	0.00168	CcSEcCtD
Epinephrine—Nervous system disorder—Prednisone—multiple sclerosis	0.000167	0.00166	CcSEcCtD
Epinephrine—Tachycardia—Prednisone—multiple sclerosis	0.000166	0.00165	CcSEcCtD
Epinephrine—Skin disorder—Prednisone—multiple sclerosis	0.000165	0.00164	CcSEcCtD
Epinephrine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000164	0.00164	CcSEcCtD
Epinephrine—CYP3A4—nervous system—multiple sclerosis	0.000162	0.00695	CbGeAlD
Epinephrine—ADRA2A—brain—multiple sclerosis	0.000157	0.00675	CbGeAlD
Epinephrine—CYP3A4—central nervous system—multiple sclerosis	0.000156	0.00669	CbGeAlD
Epinephrine—Dizziness—Prednisolone—multiple sclerosis	0.000155	0.00154	CcSEcCtD
Epinephrine—Insomnia—Prednisone—multiple sclerosis	0.000154	0.00153	CcSEcCtD
Epinephrine—Paraesthesia—Prednisone—multiple sclerosis	0.000153	0.00152	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—multiple sclerosis	0.000148	0.00147	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000147	0.00146	CcSEcCtD
Epinephrine—Dizziness—Triamcinolone—multiple sclerosis	0.000142	0.00142	CcSEcCtD
Epinephrine—Dizziness—Methylprednisolone—multiple sclerosis	0.000142	0.00141	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000139	0.00139	CcSEcCtD
Epinephrine—Nausea—Prednisolone—multiple sclerosis	0.000139	0.00138	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000137	0.00137	CcSEcCtD
Epinephrine—Vomiting—Triamcinolone—multiple sclerosis	0.000137	0.00136	CcSEcCtD
Epinephrine—Vomiting—Methylprednisolone—multiple sclerosis	0.000137	0.00136	CcSEcCtD
Epinephrine—Dizziness—Betamethasone—multiple sclerosis	0.000129	0.00128	CcSEcCtD
Epinephrine—Dizziness—Dexamethasone—multiple sclerosis	0.000129	0.00128	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—multiple sclerosis	0.000129	0.00128	CcSEcCtD
Epinephrine—Nausea—Triamcinolone—multiple sclerosis	0.000128	0.00127	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—multiple sclerosis	0.000128	0.00127	CcSEcCtD
Epinephrine—Nausea—Methylprednisolone—multiple sclerosis	0.000128	0.00127	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—multiple sclerosis	0.000126	0.00126	CcSEcCtD
Epinephrine—Vomiting—Dexamethasone—multiple sclerosis	0.000124	0.00124	CcSEcCtD
Epinephrine—Vomiting—Betamethasone—multiple sclerosis	0.000124	0.00124	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000123	0.00122	CcSEcCtD
Epinephrine—Nausea—Betamethasone—multiple sclerosis	0.000116	0.00115	CcSEcCtD
Epinephrine—Nausea—Dexamethasone—multiple sclerosis	0.000116	0.00115	CcSEcCtD
Epinephrine—Dizziness—Prednisone—multiple sclerosis	0.000113	0.00112	CcSEcCtD
Epinephrine—Vomiting—Prednisone—multiple sclerosis	0.000108	0.00108	CcSEcCtD
Epinephrine—Nausea—Prednisone—multiple sclerosis	0.000101	0.001	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—multiple sclerosis	9.4e-05	0.000935	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—multiple sclerosis	9.04e-05	0.000899	CcSEcCtD
Epinephrine—Nausea—Methotrexate—multiple sclerosis	8.45e-05	0.00084	CcSEcCtD
Epinephrine—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	1.11e-05	7.86e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	1.1e-05	7.82e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.1e-05	7.81e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	1.1e-05	7.78e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.1e-05	7.77e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL2—multiple sclerosis	1.09e-05	7.74e-05	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—IL6—multiple sclerosis	1.09e-05	7.73e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	1.09e-05	7.7e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL6—multiple sclerosis	1.09e-05	7.7e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	1.08e-05	7.7e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.08e-05	7.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	1.08e-05	7.65e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	1.07e-05	7.62e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.07e-05	7.59e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.07e-05	7.58e-05	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	1.06e-05	7.55e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	1.06e-05	7.53e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.06e-05	7.53e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.06e-05	7.51e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	1.06e-05	7.5e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	1.05e-05	7.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.05e-05	7.45e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	1.05e-05	7.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.04e-05	7.4e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	1.03e-05	7.34e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MMP9—multiple sclerosis	1.03e-05	7.33e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	1.02e-05	7.2e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.01e-05	7.2e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	1.01e-05	7.13e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	9.99e-06	7.09e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CD86—multiple sclerosis	9.93e-06	7.04e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL6—multiple sclerosis	9.92e-06	7.04e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	9.9e-06	7.02e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	9.88e-06	7.01e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	9.86e-06	6.99e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	9.79e-06	6.95e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	9.77e-06	6.93e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	9.73e-06	6.91e-05	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	9.69e-06	6.88e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	9.69e-06	6.87e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	9.66e-06	6.85e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	9.64e-06	6.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	9.63e-06	6.84e-05	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	9.6e-06	6.81e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	9.48e-06	6.73e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	9.43e-06	6.69e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	9.39e-06	6.66e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	9.39e-06	6.66e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—APOE—multiple sclerosis	9.32e-06	6.61e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	9.25e-06	6.56e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	9.24e-06	6.56e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	9.24e-06	6.56e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—STAT3—multiple sclerosis	9.18e-06	6.52e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.17e-06	6.51e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	9.17e-06	6.5e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—IL6—multiple sclerosis	9.16e-06	6.5e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.12e-06	6.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	9.1e-06	6.46e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.08e-06	6.44e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—APOE—multiple sclerosis	9.06e-06	6.43e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	9.05e-06	6.42e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	9e-06	6.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	8.99e-06	6.38e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	8.99e-06	6.38e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	8.97e-06	6.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	8.95e-06	6.35e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	8.92e-06	6.33e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	8.87e-06	6.29e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	8.83e-06	6.26e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	8.82e-06	6.26e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	8.8e-06	6.25e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	8.8e-06	6.25e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	8.79e-06	6.24e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2—multiple sclerosis	8.76e-06	6.22e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	8.76e-06	6.21e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	8.72e-06	6.19e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	8.72e-06	6.19e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	8.72e-06	6.18e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—APOE—multiple sclerosis	8.68e-06	6.16e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	8.68e-06	6.16e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	8.61e-06	6.11e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	8.56e-06	6.08e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	8.56e-06	6.07e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MYC—multiple sclerosis	8.53e-06	6.05e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TGFB1—multiple sclerosis	8.51e-06	6.04e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	8.43e-06	5.98e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.36e-06	5.93e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MAPK1—multiple sclerosis	8.35e-06	5.92e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	8.33e-06	5.91e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	8.29e-06	5.88e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	8.21e-06	5.83e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	8.21e-06	5.82e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	8.2e-06	5.82e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—APOE—multiple sclerosis	8.19e-06	5.81e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	8.15e-06	5.78e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	8.12e-06	5.76e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	8.11e-06	5.76e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	8.08e-06	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	8.08e-06	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	8.02e-06	5.69e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—APOE—multiple sclerosis	8.01e-06	5.68e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—POMC—multiple sclerosis	8e-06	5.68e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	7.95e-06	5.64e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.9e-06	5.61e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	7.84e-06	5.56e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.84e-06	5.56e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—POMC—multiple sclerosis	7.78e-06	5.52e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	7.72e-06	5.48e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	7.63e-06	5.41e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	7.58e-06	5.38e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	7.55e-06	5.36e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	7.51e-06	5.33e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	7.48e-06	5.31e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—POMC—multiple sclerosis	7.46e-06	5.29e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	7.46e-06	5.29e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CD80—multiple sclerosis	7.4e-06	5.25e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	7.39e-06	5.24e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	7.37e-06	5.23e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—APOE—multiple sclerosis	7.36e-06	5.22e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	7.33e-06	5.2e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ALB—multiple sclerosis	7.3e-06	5.18e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	7.29e-06	5.17e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	7.28e-06	5.17e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CD80—multiple sclerosis	7.24e-06	5.14e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	7.18e-06	5.09e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.15e-06	5.07e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	7.12e-06	5.05e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ALB—multiple sclerosis	7.1e-06	5.04e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—POMC—multiple sclerosis	7.03e-06	4.99e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	6.97e-06	4.94e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	6.95e-06	4.93e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	6.88e-06	4.88e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—POMC—multiple sclerosis	6.88e-06	4.88e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	6.86e-06	4.87e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	6.85e-06	4.86e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MYC—multiple sclerosis	6.85e-06	4.86e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	6.83e-06	4.85e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	6.82e-06	4.84e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ALB—multiple sclerosis	6.8e-06	4.83e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	6.76e-06	4.8e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.75e-06	4.79e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	6.74e-06	4.78e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	6.73e-06	4.78e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	6.73e-06	4.78e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	6.7e-06	4.75e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	6.67e-06	4.73e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	6.67e-06	4.73e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	6.62e-06	4.7e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	6.62e-06	4.7e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	6.59e-06	4.67e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	6.51e-06	4.62e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—multiple sclerosis	6.41e-06	4.55e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	6.41e-06	4.55e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	6.37e-06	4.52e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—POMC—multiple sclerosis	6.32e-06	4.49e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	6.27e-06	4.45e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	6.25e-06	4.43e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	6.23e-06	4.42e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	6.19e-06	4.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	6.15e-06	4.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	6.13e-06	4.35e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	6.11e-06	4.34e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	5.99e-06	4.25e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	5.78e-06	4.1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—multiple sclerosis	5.76e-06	4.09e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	5.71e-06	4.05e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	5.69e-06	4.04e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	5.69e-06	4.04e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	5.68e-06	4.03e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	5.57e-06	3.95e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	5.56e-06	3.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	5.45e-06	3.87e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	5.4e-06	3.83e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	5.29e-06	3.75e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.21e-06	3.7e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—multiple sclerosis	5.2e-06	3.69e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	5.17e-06	3.67e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	5.17e-06	3.67e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	5.15e-06	3.66e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—multiple sclerosis	5.15e-06	3.65e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	5.13e-06	3.64e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—multiple sclerosis	5.09e-06	3.61e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	5.06e-06	3.59e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	5.06e-06	3.59e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	5.06e-06	3.59e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	4.92e-06	3.49e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	4.88e-06	3.46e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	4.81e-06	3.42e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	4.81e-06	3.41e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	4.8e-06	3.41e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	4.79e-06	3.4e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—multiple sclerosis	4.75e-06	3.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	4.74e-06	3.36e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	4.71e-06	3.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	4.7e-06	3.33e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	4.55e-06	3.23e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	4.48e-06	3.18e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	4.46e-06	3.17e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	4.45e-06	3.16e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	4.38e-06	3.1e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	4.37e-06	3.1e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	4.34e-06	3.08e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	4.28e-06	3.04e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	4.21e-06	2.99e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	4.19e-06	2.97e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—POMC—multiple sclerosis	4.08e-06	2.9e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—multiple sclerosis	4.07e-06	2.88e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—multiple sclerosis	4.06e-06	2.88e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	4.06e-06	2.88e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	4.05e-06	2.87e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	4.03e-06	2.86e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	4.02e-06	2.85e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	3.99e-06	2.83e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	3.98e-06	2.83e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	3.98e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—multiple sclerosis	3.98e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	3.97e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	3.94e-06	2.8e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	3.91e-06	2.77e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	3.89e-06	2.76e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	3.89e-06	2.76e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	3.76e-06	2.67e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	3.75e-06	2.66e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—multiple sclerosis	3.72e-06	2.64e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	3.7e-06	2.63e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	3.7e-06	2.63e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	3.69e-06	2.62e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	3.68e-06	2.61e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	3.62e-06	2.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	3.54e-06	2.51e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—POMC—multiple sclerosis	3.49e-06	2.48e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	3.35e-06	2.38e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.29e-06	2.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	3.29e-06	2.33e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.28e-06	2.33e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.22e-06	2.28e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—multiple sclerosis	3.18e-06	2.26e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.14e-06	2.23e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	3.06e-06	2.17e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—multiple sclerosis	3.06e-06	2.17e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	3.05e-06	2.16e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	3.03e-06	2.15e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	2.99e-06	2.12e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—multiple sclerosis	2.99e-06	2.12e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	2.83e-06	2.01e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	2.78e-06	1.98e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.69e-06	1.91e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.47e-06	1.75e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.46e-06	1.74e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	2.3e-06	1.63e-05	CbGpPWpGaD
